2018
DOI: 10.2174/1389200219666180305154119
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics, Metabolism, Distribution and Permeability of Nanomedicine

Abstract: Nanomedicine is increasingly becoming important in the treatment of diseases and diagnosis. Size of the particle plays an important role. As the particle size decreases its effect to cure the disease increases. Pharmacokinetics, bioavailability, half-life, metabolism, biodistribution and permeability of nanomedicine were found to be better than that of microsized drugs. In vitro and In vivo ADME (Absorption, Distribution, Metabolism and Excretion) studies are mandatory for pharmaceutical organic drugs. Similar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 64 publications
(38 citation statements)
references
References 0 publications
0
38
0
Order By: Relevance
“…Nanoencapsulation of drugs and bioactive compounds with low solubility, volatility, or viscosity is an important tool to improve these characteristics and control the release profiles. In addition, nanoencapsulation can protect the molecule from premature degradation or loss of functionality, and improve the biopharmaceutical and pharmacokinetic properties, resulting in improved therapeutic efficacy (Ravindran et al, 2018;Yao, Mcclements, Xiao, 2015;Khan, Gurav, 2018;Amreddy et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Nanoencapsulation of drugs and bioactive compounds with low solubility, volatility, or viscosity is an important tool to improve these characteristics and control the release profiles. In addition, nanoencapsulation can protect the molecule from premature degradation or loss of functionality, and improve the biopharmaceutical and pharmacokinetic properties, resulting in improved therapeutic efficacy (Ravindran et al, 2018;Yao, Mcclements, Xiao, 2015;Khan, Gurav, 2018;Amreddy et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Delivery by nanocarriers generally may have varied therapeutic advantages. These advantages include, among others, an increased half-life, extended circulation time, enhanced mean residence time, and improved pharmacokinetic clearance of these agents from the body (Ravindran et al, 2018). Currently, many nanosized delivery systems intended for oral administration of phytotherapeutics have reached the clinical trial stage and are increasingly applied in clinical practice (Hajialyani et al, 2018).…”
Section: Therapeutic Nanodelivery Systemsmentioning
confidence: 99%
“…86 Nanoparticles presented in solid or liquid forms also penetrate the barriers as well as associated physical, biological, and chemical processes of the tract,consequently, altering and transforming their pharmacological and toxicological properties. 87 Importantly, particle size is an essential factor,the smaller the particle size, the more effective its disease curative effects. As a result, NPs synthesized drugs have higher penetration, proper absorption, more extensive distribution, better metabolism, and greater bioavailability compared to drugs of the same size.…”
Section: Pharmacokine Tic S Of Nanoparti Cle S In Rel Ati On To Te S Ticul Ar Tissue and B Lood-te S Tis Barriermentioning
confidence: 99%